Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
This article presents the research findings on the impact of carvedilol on the course of the necrosis myocardium focus and malone dialdegid concentration with patients, afflicted with acute myocardial infarction. The study proves that carvedilol slows down the necrosis focus formation and relieves t...
Main Authors: | T. Yu. Mamonova, V. A. Markov, V. V. Udut |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2009-04-01
|
Series: | Bûlleten' Sibirskoj Mediciny |
Subjects: | |
Online Access: | https://bulletin.tomsk.ru/jour/article/view/1801 |
Similar Items
-
PRIMARY ANGIOPLASTICS AND PHARMACOINVASIVE REPERFUSION IN MYOCARDIAL INFARCTION: IMPACT ON CLINICAL OUTCOMES AND NO-REFLOW PHENOMENON
by: E. V. Vyshlov, et al.
Published: (2015-02-01) -
No-Reflow Phenomenon in Patients with ST-Elevation Acute Myocardial Infarction, Treated with Primary Percutaneous Coronary Intervention: A Study of Predictive Factors
by: Seyed Hashem Danesh Sani, et al.
Published: (2014-11-01) -
Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion
by: X.J. Zhao, et al.
Published: (2014-03-01) -
NO-REFLOW PHENOMENON IN THE PRACTICE OF AN ENDOVASCULAR SURGEON
by: A. M. Gerasimov, et al.
Published: (2016-06-01) -
Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
by: Mohammad Alidoosti, et al.
Published: (2018-07-01)